España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Personalis
PSNL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.09
0.14
2.35%
At close: -
$6.09
0.00
0.00%
After Hours: Dec 24, 4:13 PM EDT
Get Report
Comment
Personalis (PSNL) Forecast
News
Earnings
Personalis (PSNL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Personalis (NASDAQ:PSNL) Stock
Personalis Stock (NASDAQ: PSNL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
Dow Surges Over 600 Points, Gold Jumps 1.5%
Avi Kapoor
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
Avi Kapoor
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Personalis shares are trading higher after th...
Benzinga Newsdesk
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Personal...
Benzinga Newsdesk
Thursday, December 19, 2024
Moderna and Personalis shares are trading hig...
Benzinga Newsdesk
Stock Of The Day: Where Does The Merck Downtrend End?
Mark Putrino
Personalis Signs Multi-Year Extension With Mo...
Benzinga Newsdesk
Merck Agrees To Purchase $50M Of Personalis C...
Benzinga Newsdesk
Monday, December 16, 2024
Personalis And Tempus Expand Collaboration, E...
Benzinga Newsdesk
Thursday, November 07, 2024
Key Takeaways From Personalis Analyst Ratings
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
What Analysts Are Saying About Personalis Stock
Benzinga Insights
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Wednesday, November 06, 2024
Personalis shares are trading lower after the...
Benzinga Newsdesk
Personalis Q3 2024 GAAP EPS $(0.64) Misses $(...
Benzinga Newsdesk
Personalis Raises FY2024 Sales Guidance from ...
Benzinga Newsdesk
Personalis Sees Q4 Sales $15.000M-16.000M vs ...
Benzinga Newsdesk
Monday, August 19, 2024
Assessing Personalis: Insights From 4 Financial Analysts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Personal...
Benzinga Newsdesk
Friday, August 16, 2024
BTIG Maintains Buy on Personalis, Raises Pric...
Benzinga Newsdesk
Needham Maintains Buy on Personalis, Raises P...
Benzinga Newsdesk
Personalis shares are trading higher after th...
Benzinga Newsdesk
Personalis And Tempus Expand Collaboration; T...
Benzinga Newsdesk
Monday, August 12, 2024
Personalis shares are trading higher after th...
Benzinga Newsdesk
Thursday, August 08, 2024
Personalis shares are trading higher after th...
Benzinga Newsdesk
Wednesday, August 07, 2024
Personalis Q2 2024 GAAP EPS $(0.24) Beats $(0...
Benzinga Newsdesk
Thursday, July 11, 2024
Myriad Genetics And Personalis Announce Cross...
Benzinga Newsdesk
Wednesday, July 03, 2024
Personalis 13D Filing Shows Tempus AI Reporte...
Benzinga Newsdesk
Friday, June 21, 2024
Breaking Down Personalis: 4 Analysts Share Their Views
Benzinga Insights
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Tuesday, June 04, 2024
Personalis To Present NeXT Personal Ultra-Sen...
Benzinga Newsdesk
Monday, June 03, 2024
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Friday, May 31, 2024
Personalis Announces Tempus Begins Commercial...
Benzinga Newsdesk
Thursday, May 09, 2024
4 Analysts Have This To Say About Personalis
Benzinga Insights
Personalis shares are trading higher after th...
Benzinga Newsdesk
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Wednesday, May 08, 2024
Personalis Sees Q2 Revenue $19.5M-$20.5M vs $...
Benzinga Newsdesk
Personalis Q1 2024 GAAP EPS $(0.26) Beats $(0...
Benzinga Newsdesk
Tuesday, April 30, 2024
Lake Street Initiates Coverage On Personalis ...
Benzinga Newsdesk
Wednesday, April 17, 2024
Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
Shanthi Rexaline
Thursday, April 11, 2024
Needham Reiterates Buy on Personalis, Maintai...
Benzinga Newsdesk
Thursday, April 04, 2024
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
Benzinga Neuro
Friday, March 29, 2024
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Benzinga Neuro
Tuesday, March 26, 2024
Personalis Announces Publication Validating N...
Benzinga Newsdesk
Thursday, March 21, 2024
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
Benzinga Neuro
Wednesday, March 20, 2024
Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
Benzinga Neuro
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch